GlassScriptPhysician profile
Megan L Panico
NPI 1669633251
$3,762.06
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,681 · 2020: $328 · 2021: $1,025 · 2022: $684 · 2023: $23.84 · 2024: $20.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,288.60 | 2019-2022 | |
| Glaxosmithkline, LLC. | $934.01 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $300.44 | 2019-2021 | |
| Mylan Specialty L.P. | $271.07 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.91 | 2019-2022 | |
| Genentech USA, INC. | $98.60 | 2019 | |
| Advanced Respiratory, INC | $77.79 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $71.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $66.73 | 2019 | |
| Merck Sharp & Dohme LLC | $55.27 | 2019 | |
| Alexion Pharmaceuticals, INC. | $53.10 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $48.91 | 2019-2021 | |
| Allergan, INC. | $38.94 | 2019 | |
| Mallinckrodt Enterprises LLC | $35.37 | 2019 | |
| Insmed, INC. | $32.35 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $30.00 | 2019 | |
| Circassia INC. | $27.92 | 2019 | |
| Phadia US INC. | $23.04 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.19 | 2020 | |
| Genzyme Corporation | $17.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Panico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.